title: Sertraline in social phobia.
authors.forename: V D
authors.initials: VD
authors.lastname: Czepowicz
authors.forename: M R
authors.initials: MR
authors.lastname: Johnson
authors.forename: R B
authors.initials: RB
authors.lastname: Lydiard
authors.forename: N P
authors.initials: NP
authors.lastname: Emmanuel
authors.forename: M R
authors.initials: MR
authors.lastname: Ware
authors.forename: O B
authors.initials: OB
authors.lastname: Mintzer
authors.forename: M D
authors.initials: MD
authors.lastname: Walsh
authors.forename: J C
authors.initials: JC
authors.lastname: Ballenger
mesh_terms: D015057:1-Naphthylamine / Q000009:adverse effects / Q000031:analogs & derivatives* / Q000627:therapeutic use; D000328:Adult; D004305:Dose-Response Relationship, Drug; D004334:Drug Administration Schedule; D005260:Female; D006801:Humans; D008297:Male; D010698:Phobic Disorders / Q000188:drug therapy* / Q000523:psychology; D017367:Selective Serotonin Reuptake Inhibitors / Q000009:adverse effects / Q000627:therapeutic use*; D020280:Sertraline; D016896:Treatment Outcome
chemical_list: D015057:1-Naphthylamine; D017367:Selective Serotonin Reuptake Inhibitors; D020280:Sertraline